Showing results (161-170 of 209) with videos related to
Sort By:
Pageof 21
The American Journal of Psychiatry|May 4, 2004
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodiesClive G Ballard, Robin Jacoby, Teodoro Del Ser, et al.Frontiers in Immunology|November 9, 2020
Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic NeurodegenerationJuliane Obst, Emilie Simon, Maria Martin-Estebane, et al.Cell Reports|April 25, 2019
The Major Risk Factors for Alzheimer's Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ PlaquesCarlo Sala Frigerio, Leen Wolfs, Nicola Fattorelli, et al.Journal of Alzheimer'S Disease : JAD|December 12, 2025
Periodontitis and incident cognitive decline and dementia: A 15-year prospective cohort study of older men residing in Northern IrelandDominic N Farsi, Rena Abadalkareem, Gerry J Linden, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 25, 2009
Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial)Clive Ballard, Richard Brown, Jane Fossey, et al.Nature Reviews. Drug Discovery|November 6, 2012
Drug repositioning for Alzheimer's diseaseAnne Corbett, James Pickett, Alistair Burns, et al.Nature Neuroscience|October 30, 2019
Stem-cell-derived human microglia transplanted in mouse brain to study human diseaseRenzo Mancuso, Johanna Van Den Daele, Nicola Fattorelli, et al.The New England Journal of Medicine|October 5, 2007
Donepezil for the treatment of agitation in Alzheimer's diseaseRobert J Howard, Edmund Juszczak, Clive G Ballard, et al.Trials|July 20, 2016
A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocolCaroline Greenan, Lynn Murphy, Ly-Mee Yu, et al.Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.Pageof 21